WGU D027
Autosomal Dominant .......Answer.........1 parent has, 50% change
of child having
Autosomal Recessive .......Answer.........Both parents are carriers,
25% change of child having, 50% chance child is a carrier.
Cystic Fibrosis .......Answer.........affects pancreas causing
secretions in lungs
A 45-year-old female patient presents to a clinic complaining of
chronic generalized pain and wishes to be evaluated for
fibromyalgia and chronic pain syndrome. A thorough history and
physical is conducted, and the findings are negative. The patient
is not taking any medications, has no allergies to medicines, and
has a negative past medical history.
,age 2 of 171
What is an appropriate first intervention for this patient?
.......Answer.........Assess the patient's sleep hygiene and make
recommendations -
The most noninvasive approach to assessing generalized pain
that seems to have no etiologic physical findings of chronic
fatigue, chronic pain syndrome, or fibromyalgia is to further
assess the patient's sleep history. Lack of adequate sleep has
been linked to myalgias and chronic pain. Often a vicious cycle
occurs in which the pain induced by lack of sleep then causes
inability to sleep and so on.
A 55-year-old male patient is on a medical floor for respite
care. He is currently in hospice for end-stage pancreatic cancer.
During assessment, a nurse notices that he is diaphoretic,
moaning, and clutching his abdomen. He rates his pain at a nine
,age 3 of 171
out of ten. The nurse notes that his abdomen is distended, and he
has rebound tenderness in all four quadrants.
What is an appropriate nursing intervention for this patient?
.......Answer.........Giving a dose of intravenous morphine
(Duramorph) -
The key information in this scenario is that the patient is in
hospice for end-stage pancreatic cancer. He is in significant
pain, and none of the options other than the administration of
morphine (Duramorph) are likely to provide the level of pain
reduction necessary. Hospice care is guided by the approach to
providing maximum comfort for individuals at the end of life
through a peaceful, symptom-free, and dignified transition to
death when disease has advanced beyond cure.
21st Trisomy .......Answer.........Down Syndrome
, age 4 of 171
Klinefelter Syndrome (XXY) .......Answer.........male has extra X,
female like qualities
Turner Syndrome .......Answer.........Missing X in females
Alpha Thalassemia .......Answer.........inherited blood disorder;
mild to severe anemia
Beta Thallasemia .......Answer.........low hemoglobin;
contraindicated medication ferrous sulfate
Prevalence Risk .......Answer.........proportion of the population
affected at a certain time
Incidence rate .......Answer.........number of new cases divided by
population
Innate immunity .......Answer.........inflammation; increased vascular
permeability